We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Risk Factors for Venous Thromboembolism

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00018772
First Posted: July 5, 2001
Last Update Posted: January 21, 2009
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
VA Office of Research and Development
  Purpose
Deep venous thrombosis is the presence of blood clots, usually in the legs that lead to either local problems or breathing problems if the clot moves to the lungs. This study is designed to assess both clinical conditions as well as common genetic factors that lead to more risk of deep venous thrombosis. Clinical conditions of venous thrombosis include: stroke, malignancy, and situations such as surgery, pregnancy, trauma, or travel.

Condition
Deep Venous Thrombosis Pulmonary Embolism

Study Type: Observational
Study Design: Time Perspective: Prospective
Official Title: 2779 Epidemiology of Genetic and Acquired Risk Factors for Venous Thrombosis

Resource links provided by NLM:


Further study details as provided by VA Office of Research and Development:

Study Start Date: April 1999
Estimated Study Completion Date: April 2003
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria
Patients must be 18 years with the ability to understand and consent to questionnaire and blood draw, including understanding of genetic testing..
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00018772


Locations
United States, Colorado
VAMC
Denver, Colorado, United States, 80220
Sponsors and Collaborators
VA Office of Research and Development
Investigators
OverallOfficial: Richard Marlar, Ph.D.
  More Information

ClinicalTrials.gov Identifier: NCT00018772     History of Changes
Other Study ID Numbers: HEMA-013-98F
First Submitted: July 3, 2001
First Posted: July 5, 2001
Last Update Posted: January 21, 2009
Last Verified: December 2004

Keywords provided by VA Office of Research and Development:
coagulation
thrombosis genetic markers

Additional relevant MeSH terms:
Thrombosis
Embolism
Venous Thromboembolism
Pulmonary Embolism
Venous Thrombosis
Embolism and Thrombosis
Vascular Diseases
Cardiovascular Diseases
Thromboembolism
Lung Diseases
Respiratory Tract Diseases


To Top